We are live on ! Find out more
AMAL icon

Amalgamated Financial

86 hedge funds and large institutions have $206M invested in Amalgamated Financial in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 32 increasing their positions, 28 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 28

6% more capital invested

Capital invested by funds: $194M → $206M (+$11.9M)

0.34% less ownership

Funds ownership: 37.26%36.92% (-0.34%)

1% less funds holding

Funds holding: 8786 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

Holders
86
Holders Change
-1
Holders Change %
-1.15%
% of All Funds
1.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
32
Reduced
28
Closed
9
Calls
Puts
Net Calls
Net Calls Change

AMAL Hedge Fund Activity: Q1 2022 in Review

86 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Amalgamated Financial (AMAL) for Q1 2022, worth a combined $206M — up 6.1% from $194M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of AMAL and 8 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 32 added.

The largest buyer was DekaBank Deutsche Girozentrale, adding an estimated $1.54M. The largest seller was Nuveen, cutting an estimated $1.81M.

  • 86 institutional investors held Amalgamated Financial (AMAL) as of Q1 2022, down from 87 in Q4 2021.
  • Funds reported $206M of Amalgamated Financial stock for Q1 2022, up 6.1% quarter-over-quarter.
  • 8 funds opened new Amalgamated Financial positions in Q1 2022 and 9 closed out, a net change of -1 holder.
  • The largest Amalgamated Financial buyer in Q1 2022 was DekaBank Deutsche Girozentrale, an estimated $1.54M added.
  • The largest Amalgamated Financial seller in Q1 2022 was Nuveen, an estimated $1.81M sold.

Based on aggregated 13F filings for Q1 2022.